Biography
Spencer Talbot is an associate in Weil’s Antitrust practice group where he focuses on antitrust litigation, counseling, and government investigations. He works on matters across a wide range of industries, including pharmaceuticals, life sciences, technology, consumer goods, entertainment, retail, and construction.
Spencer also maintains an active pro bono practice, recently representing intervening New York City residents before the New York Court of Appeals in connection with a local law to enfranchise lawful permanent residents to vote in municipal elections.
Spencer received his J.D. from Cornell Law School, where he was a Notes Editor for the Cornell Law Review. He received his B.A. from University of California, San Diego.
Spencer’s recent experience includes serving on Weil teams representing:
- NanoString Technologies in a patent and antitrust litigation against 10x Genomics and Harvard College for allegedly monopolizing the worldwide Single-Cell Spatial Transcriptomics market by refusing to license at issue patents.
- Regeneron Pharmaceuticals in connection with monopolization, restraint of trade, and other claims against Novartis and Vetter relating to actions taken to prevent competition from Regeneron’s PFS version of EYLEA.
- Serta Simmons Bedding in connection with the FTC investigation, and subsequent litigation, of Tempur Sealy’s acquisition of Mattress Firm.
- A C-suite executive in a U.S. Department of Justice grand jury cartel investigation.